| IUPAC name | (4R)-4-[(3R,5R,6S,8S,9S,10R,13R,14S,17R)-3,6-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid |
| inchi | InChI=1S/C24H40O4/c1-14(4-7-22(27)28)17-5-6-18-16-13-21(26)20-12-15(25)8-10-24(20,3)19(16)9-11-23(17,18)2/h14-21,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15-,16+,17-,18+,19+,20+,21+,23-,24-/m1/s1 |
| inchi key | DGABKXLVXPYZII-SIBKNCMHSA-N |
| molecular formula | C24H40O4 |
| synonyms | HYODEOXYCHOLIC ACID83-49-8Hyodesoxycholic acidHDCAIodeoxycholic acid |
| Compound Description | Hyodeoxycholic acid is a member of the class of 5beta-cholanic acids that is -cholan-24-oic acid substituted by alpha-hydroxy groups at positions 3 and 6. It has a role as a human metabolite and a mouse metabolite. It is a bile acid, a member of 5beta-cholanic acids, a 6alpha,20xi-murideoxycholic acid and a C24-steroid. It is functionally related to a cholic acid. It is a conjugate acid of a hyodeoxycholate.Hyodeoxycholic Acid has been used in trials studying the treatment of Hypercholesterolemia.HYODEOXYCHOLIC_ACID is a small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication. |
